| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5384 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2793 | 2020 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1688 | 2020 |
| Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised … H Shakur, I Roberts, B Fawole, R Chaudhri, M El-Sheikh, A Akintan, ... The Lancet 389 (10084), 2105-2116, 2017 | 1433 | 2017 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1354 | 2021 |
| The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria International Team for the Revision of the International Criteria for Behçet ... Journal of the european Academy of Dermatology and Venereology 28 (3), 338-347, 2014 | 972 | 2014 |
| North American and European porcine reproductive and respiratory syndrome viruses differ in non-structural protein coding regions R Allende, TL Lewis, Z Lu, DL Rock, GF Kutish, A Ali, AR Doster, ... Journal of General Virology 80 (2), 307-315, 1999 | 567 | 1999 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 548* | 2021 |
| Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study BM Biccard, TE Madiba, HL Kluyts, DM Munlemvo, FD Madzimbamuto, ... The Lancet 391 (10130), 1589-1598, 2018 | 526 | 2018 |
| Database resources of the national genomics data center, China national center for bioinformation in 2022 Nucleic Acids Research 50 (D1), D27-D38, 2022 | 485 | 2022 |
| Revisiting the environmental Kuznets curve in a global economy M Shahbaz, I Ozturk, T Afza, A Ali Renewable and sustainable energy reviews 25, 494-502, 2013 | 399 | 2013 |
| Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial RJ McManus, J Mant, M Franssen, A Nickless, C Schwartz, J Hodgkinson, ... The Lancet 391 (10124), 949-959, 2018 | 385 | 2018 |
| THE IMPACT OF GLOBALIZATION ON CO2 EMISSIONS IN CHINA M Shahbaz, S Khan, A Ali, M Bhattacharya The Singapore Economic Review 62 (04), 929-957, 2017 | 365 | 2017 |
| Loss of Cav1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness SM Baig, A Koschak, A Lieb, M Gebhart, C Dafinger, G Nürnberg, A Ali, ... Nature neuroscience 14 (1), 77-84, 2011 | 363 | 2011 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 321 | 2021 |
| Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international … I Roberts, H Shakur-Still, A Afolabi, A Akere, M Arribas, A Brenner, ... The Lancet 395 (10241), 1927-1936, 2020 | 315 | 2020 |
| Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) A Flaxman, NG Marchevsky, D Jenkin, J Aboagye, PK Aley, B Angus, ... The Lancet 398 (10304), 981-990, 2021 | 276 | 2021 |
| Corporate governance and corporate social responsibility disclosure: evidence from Pakistan E Javaid Lone, A Ali, I Khan Corporate Governance: The international journal of business in society 16 (5 …, 2016 | 271 | 2016 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 248 | 2021 |
| Enantioselective total syntheses of manzamine A and related alkaloids JM Humphrey, Y Liao, A Ali, T Rein, YL Wong, HJ Chen, AK Courtney, ... Journal of the American Chemical Society 124 (29), 8584-8592, 2002 | 238 | 2002 |
